Form 4: Boston Scientific Director Edward J. Ludwig Reports Stock Sale

Director Edward J. Ludwig sold 12,000 shares of Boston Scientific (BSX) common stock at an average price of $105.4846 on February 11, 2025, while also receiving 3,000 shares as a gift.

Summary

• On February 11, 2025, Edward J. Ludwig, a director of Boston Scientific (BSX), reported a transaction involving the company's common stock.
• Ludwig sold 12,000 shares at a weighted average price of $105.4846, resulting in a remaining direct ownership of 24,398 shares.
• The sale occurred in multiple transactions with prices ranging from $105.47 to $105.55.
• Additionally, Ludwig acquired 3,000 shares as a gift, increasing his direct ownership before the sale.
• Following the reported transactions, Ludwig directly owns 24,398 shares of Boston Scientific common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors. It's a standard practice for publicly traded companies and their executives.

Stakeholder Impact

• The stock sale by a director could be perceived in various ways by stakeholders.
• Some might see it as a lack of confidence in the company's future, while others might view it as a personal financial decision with no bearing on the company's prospects.

Key Dates

Keywords

Form 4, Director, Stock Sale, Beneficial Ownership, Boston Scientific, BSX, Edward J. Ludwig